- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Hospitalized patients with RSV infections are at higher risk of mortality, finds study
A new study published in the journal of Open Forum Infectious Diseases showed that older adults hospitalized with respiratory syncytial virus (RSV) infections have a higher risk of dying within 90 days of admission than patients admitted with influenza B, but comparable to those admitted with influenza A.
Adults who have severe acute respiratory infections (SARI) have been linked to respiratory syncytial virus in recent years. Adults with underlying comorbidities such as immunodeficiency and chronic obstructive pulmonary disease (COPD) are more susceptible to severe RSV infection, which increases the risk of adverse outcomes and a worsening of the condition. Adults with RSV can experience mild cold-like symptoms all the way up to severe respiratory distress. According to recent research conducted in the USA and Israel, hospitalizations associated to RSV are less common than influenza, but the severity of RSV infection is on par with or even higher than influenza. This study was to compare the clinical features and symptoms of individuals hospitalized with RSV to those hospitalized with influenza A or B. Also, to compare the illness severity and fatality rates of RSV and influenza A and B patients. And lastly to determine the risk factors for death in RSV and influenza A and B patients.
After controlling for covariates, this multicenter observational cohort study examined the clinical symptoms, mortality risk factors and correlation with 90-day mortality by logistic regression analysis among persons hospitalized with RSV or influenza A or B between March 2016 and April 2020. Out of the 988 patients that were admitted to the hospital, 353 had RSV, 288 had influenza B and 347 had influenza A. Patients with RSV were more likely to have pneumonia and comorbidities when compared to influenza A and B. RSV infection was linked, relative to influenza B infection but not influenza A infection, to a higher all-cause mortality within 90 days after covariate correction. In patients with RSV, becoming older and having pneumonia at the time were found to be independent risk factors for death. Overall, RSV-induced acute respiratory infections cause considerable morbidity and death in older persons.
Source:
Clausen, C. L., Egeskov-Cavling, A. M., Hayder, N., Sejdic, A., Roed, C., Gitz Holler, J., Nielsen, L., Eiberg, M. F., Rezahosseini, O., Østergaard, C., Barrella Harboe, Z., K Fischer, T., Benfield, T., & Lindegaard, B. (2024). Clinical manifestations and outcomes in adults hospitalized with respiratory syncytial virus and influenza A/B: A multicenter observational cohort study. In Open Forum Infectious Diseases. Oxford University Press (OUP). https://doi.org/10.1093/ofid/ofae513
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751